December 2008 Corrections Page
An article originally published Dec. 10, Elan's Martin Named Worst Biotech CEO of '08, incorrectly stated that Louis Bucalo is the chief executive of Titan Pharmaceuticals (TTP:Amex). In fact, Marc Rubin has been Titan's president and CEO since October 2007. Prior to that time, Bucalo held the titles of CEO, president and chairman. Bucalo continued to serve as chairman until April 2008, when he left the board of directors. TheStreet.com regrets the error. (Corrected Dec. 11.)
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,433.49 | 1,109.19 | 2,196.78 | 34.40 |
Oil *
77.31
|
|
UP
44.59
|
UP
3.21
|
UP
2.43
|
DOWN
0.43
|
10 Yr
3.44%
SPDR Gold
113.61
|
|
+0.43%
|
+0.29%
|
+0.11%
|
-1.23%
|
Data delayed 20 minutes |
